The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Study on the safety and immunogenicity of enterotoxigenic Escherichia coli recombinant active vaccine
Author(s): 
Pages: 515-519
Year: Issue:  7
Journal: CHINESE JOURNAL OF EPIDEMIOLOGY

Keyword:  肠毒素大肠埃希菌疫苗免疫性;
Abstract: 目的研究肠毒素大肠埃希菌活菌载体疫苗FE3、FE16的安全性和免疫原性.方法通过肠毒素大肠埃希菌肠毒素毒力试验、新西兰大白兔免疫试验、小鼠口服和鼻饲途径免疫试验,检测载体疫苗的毒性、免疫原性和免疫效果.结果毒力试验中所有检测均为阴性;免疫4次后大白兔血清对福氏2a型菌的凝集效价均不低于1:640,对肠毒素大肠埃希菌菌毛抗原的凝集效价均不低于1:1280;通过口服和鼻饲方式免疫小鼠后,血清中IgG显著升高,同时能够在粪便中检测到分泌型IgA,而灭活苗免疫未能检测到分泌型IgA.结论活菌载体疫苗株FE3和FE16具有良好的安全性和免疫原性,同时能够刺激机体产生体液免疫和黏膜免疫反应.
Related Articles
loading...